Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)
This study has been completed.
Study NCT01176903 Information provided by Chiesi Farmaceutici S.p.A.
First Received on August 5, 2010. Last Updated on December 14, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
More general conditions related to this trial
Respiratory Tract Diseases
Interventions listed in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Physiological Effects of Drugs
Respiratory System Agents
Sponsors listed in this trial
Chiesi Farmaceutici S.p.A.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers